BNP Paribas Financial Markets’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.6K | Buy |
2,103
+535
| +34% | +$8.56K | ﹤0.01% | 3581 |
|
|
2025
Q1 | $23.8K | Sell |
1,568
-1,803
| -53% | -$27.4K | ﹤0.01% | 3659 |
|
|
2024
Q4 | $68.4K | Sell |
3,371
-9,977
| -75% | -$202K | ﹤0.01% | 3464 |
|
|
2024
Q3 | $343K | Sell |
13,348
-1,132
| -8% | -$29.1K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $186K | Buy |
14,480
+13,134
| +976% | +$169K | ﹤0.01% | 2457 |
|
|
2024
Q1 | $30.8K | Buy |
+1,346
| New | +$30.8K | ﹤0.01% | 2948 |
|
|
2022
Q4 | – | Sell |
-2,448
| Closed | -$64.4K | – | 3878 |
|
|
2022
Q3 | $64.4K | Buy |
+2,448
| New | +$64.4K | ﹤0.01% | 3216 |
|